Target Name: GYPB
NCBI ID: G2994
Review Report on GYPB Target / Biomarker Content of Review Report on GYPB Target / Biomarker
GYPB
Other Name(s): blood group system MNSs, St(a) type E | glycophorin A | GYPB-A fusion | sialoglycoprotein delta | Sialoglycoprotein delta | GYPB variant 1 | Glycophorin MiVI | GPB | glycophorin B/glycophorin A fusion protein | HGpMiVI | GYPHe.NY | Glycophorin B (MNS blood group), transcript variant 1 | GLPB_HUMAN | Glycophorin HeP2 | glycophorin B (MNS blood group) | GYPA | GYPB-A-B fusion | PAS-3 | MNS | Glycophorin-B | OTTHUMP00000220168 | blood group system MNSs, Mur-like | GYPB/GYPA fusion | OTTHUMP00000220160 | Ss blood group | SS-active sialoglycoprotein | glycophorin B, blood group system Ss, S, Mit+ | CD235b | GPB.NY | hybrid glycophorin Kip | SS | Ss sialoglycoprotein | glycophorin B blood group antigen | OTTHUMP00000220163 | blood group system MNSs, St(a) type F | GYP | glycophorin Hop | Glycophorin-B isoform 1 precursor (isoform 1)

GYPB: A Blood Group Protein and Potential Drug Target

The GYPB (Glycophorin A protein) blood group system is a type of biomarker that is expressed in the major nucleated cells of the body, including red blood cells, white blood cells, and platelets. It is a transmembrane protein that is involved in the regulation of various physiological processes in the body, including blood clotting, inflammation, and immune responses.

GYPB is a member of the major blood group systems (MNSs), which include A, B, AB, and O blood groups. These blood groups are determined by the presence or absence of specific antigens on the surface of red blood cells. GYPB is expressed in all nucleated cells of the body and is a key determinant of blood group.

GYPB is involved in many different physiological processes in the body, including:

1. Blood clotting: GYPB is a key protein involved in the regulation of blood clotting. It helps to clot blood vessels, which helps to prevent blood from leaking out and forming clots.
2. Inflammation: GYPB is involved in the regulation of inflammatory responses. When the body is injured or infected, GYPB helps to recruit immune cells to the site of injury or infection.
3. Immune responses: GYPB is involved in the regulation of the immune response. It helps to stimulate the production of antibodies, which are proteins that are responsible for fighting off infections.
4. Cell signaling: GYPB is involved in cell signaling. It plays a role in the regulation of cell growth, differentiation, and death.

GYPB is also a potential drug target. Researchers are interested in using GYPB as a drug target because of its involvement in various physiological processes in the body.

One way that researchers are interested in using GYPB as a drug target is to use it to treat blood clots. Blood clots can be a serious condition that can lead to serious complications, including heart attacks, strokes, and death. GYPB is involved in the regulation of blood clotting, so researchers are interested in using GYPB as a drug to treat blood clots.

Another way that researchers are interested in using GYPB as a drug target is to use it to treat inflammation. Inflammation can be a sign of an underlying infection or injury, and it can cause pain, swelling, and other symptoms. GYPB is involved in the regulation of inflammatory responses, so researchers are interested in using GYPB as a drug to treat inflammation.

GYPB is also a potential biomarker for certain diseases. For example, GYPB is often used as a diagnostic marker for liver disease. Researchers are also interested in using GYPB as a biomarker for other diseases, such as cancer, diabetes, and cardiovascular disease.

Overall, GYPB is a blood group system protein that is expressed in all nucleated cells of the body. It is involved in various physiological processes in the body, including blood clotting, inflammation, and immune responses. As a result, GYPB is a potential drug target and a potential biomarker for certain diseases.

Protein Name: Glycophorin B (MNS Blood Group)

Functions: This protein is a minor sialoglycoprotein in erythrocyte membranes

The "GYPB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GYPB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44